1. High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus–Coinfected Women
   Ani Kardashian et al, 2019, Open Forum Infectious Diseases CrossRef
2. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
   Michael Platten et al, 2019, Nature Reviews Drug Discovery CrossRef
3. The Janus-Faced Nature of Ido1 in Infectious Diseases: Challenges and Therapeutic Opportunities
   Francesco Antonio Greco et al, 2016, Future Medicinal Chemistry CrossRef
4. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS
   Mohamed Labib Salem et al, 2017, Immunopharmacology and Immunotoxicology CrossRef
5. Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
   Kashif Asghar et al, 2017, World Journal of Gastroenterology CrossRef
6. Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
   Vikram Mehraj et al, 2015, International Journal of Tryptophan Research CrossRef
7. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation
   Weichao Zhong et al, 2017, Oncotarget CrossRef
8. Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses
   Shivana M. Lightman et al, 2021, Immunity CrossRef
9. Novel Immunotherapy Strategies for Hepatobiliary Cancers
   Thomas T DeLeon et al, 2018, Immunotherapy CrossRef
10. Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma
    Shigemune Bekki et al, 2020, PLOS ONE CrossRef
11. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies
    Jingpu Zhang et al, 2024, Inflammation Research CrossRef
12. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
    Mohammad-Ali Jenabian et al, 2016, JAIDS Journal of Acquired Immune Deficiency Syndromes CrossRef
13. The footprint of kynurenine pathway in every cancer: a new target for chemotherapy
    Moein Ala, 2021, European Journal of Pharmacology CrossRef
14. Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitis
    Alexander Lercher et al, 2020, PLOS Pathogens CrossRef